Homology modeling, docking, molecular dynamics simulation, and structural analyses of coxsakievirus B3 2A protease: an enzyme involved in the pathogenesis of inflammatory myocarditis.

2A protease of the pathogenic coxsackievirus B3 is key to the pathogenesis of inflammatory myocarditis and, therefore, an attractive drug target. However lack of a crystal structure impedes design of inhibitors. Here we predict 3D structure of CVB3 2A(pro) based on sequence comparison and homology modeling with human rhinovirus 2A(pro). The two enzymes are remarkably similar in their core regions. However they have different conformations at the N-terminal. A large number of N-terminal hydrophobic residues reduce the thermal stability of CVB3 2A(pro), as we confirmed by fluorescence, western blot and turbidity measurement. Molecular dynamic simulation revealed that elevated temperature induces protein motion that results in frequent movement of the N-terminal coil. This may therefore induce successive active site changes and thus play an important role in destabilization of CVB3 2A(pro) structure.

[1]  Woodruff Jf.  Viral myocarditis. A review. , 1980 .

[2]  R. Kandolf,et al.  Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes. , 1998, Circulation.

[3]  M. Sabbaghian,et al.  Purification and partial characterization of coxsackievirus B3 2A protease expressed in Escherichia coli. , 2008, International journal of biological macromolecules.

[4]  P. Horowitz,et al.  Detergent-assisted refolding of guanidinium chloride-denatured rhodanese. The effects of the concentration and type of detergent. , 1987, The Journal of biological chemistry.

[5]  D. Ritchie,et al.  Protein docking using spherical polar Fourier correlations , 2000, Proteins.

[6]  N. Guex,et al.  SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.

[7]  J. Whitton,et al.  The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis , 1995, Journal of virology.

[8]  M. James,et al.  The structure of the 2A proteinase from a common cold virus: a proteinase responsible for the shut‐off of host‐cell protein synthesis , 1999, The EMBO journal.

[9]  K. Klingel,et al.  Molecular pathogenesis of enterovirus-induced myocarditis: virus persistence and chronic inflammation. , 1993, Intervirology.

[10]  M. Martone,et al.  Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy , 1999, Nature Medicine.

[11]  N. Dalton,et al.  Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. , 1998, The Journal of clinical investigation.

[12]  Maryam Moosavi,et al.  Targeting enteroviral 2A protease by a 16-mer synthetic peptide: inhibition of 2Apro-induced apoptosis in a stable Tet-on HeLa cell line. , 2010, Virology.

[13]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[14]  Manuel C. Peitsch,et al.  SWISS-MODEL: an automated protein homology-modeling server , 2003, Nucleic Acids Res..

[15]  D. Hassett,et al.  Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease. , 2003, The American journal of pathology.

[16]  R. Hruban,et al.  Inducible nitric oxide synthase protection against coxsackievirus pancreatitis. , 1999, Journal of immunology.

[17]  Vijay S. Pande,et al.  Accelerating molecular dynamic simulation on graphics processing units , 2009, J. Comput. Chem..

[18]  K. Klingel,et al.  Cardioselective Infection With Coxsackievirus B3 Requires Intact Type I Interferon Signaling: Implications for Mortality and Early Viral Replication , 2001, Circulation.

[19]  R. Rhoads,et al.  Protection of Cap-dependent Protein Synthesisin Vivo and in Vitro with an eIF4G-1 Variant Highly Resistant to Cleavage by Coxsackievirus 2A Protease* , 2003, The Journal of Biological Chemistry.

[20]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[21]  R. Yazdanparast,et al.  Artificial Chaperone-assisted Refolding of GuHCl-Denatured α-Amylase at Low Temperature: Refolding versus Aggregation , 2005, The protein journal.

[22]  Albert Heim,et al.  Cultured human myocardial fibroblasts of pediatric origin: Natural human interferon-α is more effective than recombinant interferon-α 2a in carrier-state coxsackievirus B3 replication , 1995 .

[23]  A. Sali,et al.  Protein Structure Prediction and Structural Genomics , 2001, Science.

[24]  E. Ehrenfeld,et al.  Translation of poliovirus RNA in vitro: changes in cleavage pattern and initiation sites by ribosomal salt wash. , 1979, Virology.

[25]  A. Sall,et al.  Coxsackievirus B3 proteases 2A and 3C induce apoptotic cell death through mitochondrial injury and cleavage of eIF4GI but not DAP5/p97/NAT1 , 2007, Apoptosis.

[26]  C. Tsou.  Inactivation precedes overall molecular conformation changes during enzyme denaturation. , 1995, Biochimica et biophysica acta.

[27]  R. Wessely.  Coxsackieviral replication and pathogenicity: lessons from gene modified animal models , 2004, Medical Microbiology and Immunology.